Evofem Biosciences (EVFM) Shares Outstanding (2014 - 2026)
Evofem Biosciences (EVFM) reported Shares Outstanding of 137.34 million for Q2 2026, up 18.7% from 115.69 million a year earlier and up 3.1% from the prior quarter.
Powered by 
Analysis
Evofem Biosciences (EVFM) Shares Outstanding (2014 - 2026) Analysis & Trends
For FY2025, Evofem Biosciences posted Shares Outstanding of 123.66 million, up 64.4% from FY2024.
- Shares Outstanding has a five-year compound annual growth rate of 94.2% (FY2020 to FY2025).
- By year, Shares Outstanding came in at 75.2 million in FY2024, 4.83 million in FY2023 (-91.7%), 58.25 million in FY2022 (+567.4%) and 8.73 million in FY2021 (+94.9%).
- The Q2 2026 figure ranks as the highest quarterly Shares Outstanding in data going back to Q1 2014.
- Year over year, Shares Outstanding has now increased in each of the last six quarters, with growth averaging 76.9% over the last six quarters.
- The high point for year-over-year Shares Outstanding in five years was Q3 2022 (growth of 701.5%); the low point was Q3 2023 (a decline of 94.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 133.25 million (Q1 2026), 123.66 million (Q4 2025) and 119.58 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.71 Bn | 1,140.30 Bn | 19.71 Bn | 892.40 Mn |
| 2 | Johnson & Johnson | 642.13 Bn | 560.65 Bn | 17.26 Bn | 2.41 Bn |
| 3 | AbbVie | 501.64 Bn | 474.75 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 375.66 Bn | 330.04 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 302.79 Bn | 266.78 Bn | 11.24 Bn | 1.94 Bn |
| 6 | Astrazeneca | 268.68 Bn | 242.37 Bn | 12.86 Bn | 1.55 Bn |
| 7 | Amgen | 242.43 Bn | 197.83 Bn | 7.24 Bn | 540.00 Mn |
| 8 | Gilead Sciences | 193.69 Bn | 167.89 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 172.47 Bn | 119.12 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Evofem Biosciences | 1.33 Mn | 1.33 Mn | 2.12 Mn | 137.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 137.34 Mn |
| Mar 31, 2026 | 133.25 Mn |
| Dec 31, 2025 | 123.66 Mn |
| Sep 30, 2025 | 119.58 Mn |
| Jun 30, 2025 | 115.69 Mn |
| Mar 31, 2025 | 113.36 Mn |
| Dec 31, 2024 | 75.20 Mn |
| Sep 30, 2024 | 96.46 Mn |
| Jun 30, 2024 | 66.77 Mn |
| Mar 31, 2024 | 31.19 Mn |
| Dec 31, 2023 | 4.83 Mn |
| Sep 30, 2023 | 4.24 Mn |
| Jun 30, 2023 | 1.58 Mn |
| Mar 31, 2023 | 1.27 Mn |
| Dec 31, 2022 | 58.25 Mn |
| Sep 30, 2022 | 82.44 Mn |
| Jun 30, 2022 | 27.13 Mn |
| Mar 31, 2022 | 11.09 Mn |
| Dec 31, 2021 | 8.73 Mn |
| Sep 30, 2021 | 10.28 Mn |
API Access
Evofem Biosciences Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=EVFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();